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Splicing for survival
 
The oncogene 
 
BCR–ABL1
 
 hijacks a B cell 
signaling protein by inducing the synthesis 
of a linker protein, according to Feldhahn 
and colleagues on page 1837. This study 
helps explain how BCR–ABL1 causes B cell 
leukemias in humans and identifies a 
potential new target for drug development.
Translocation events that combine 
unrelated chromosomal sequences are 
found in up to 65% of human acute 
leukemias. One such translocation event 
creates a chimeric protein between the 
signaling protein BCR and the tyrosine 
kinase ABL1. The BCR–ABL1 fusion allows 
precursor B cells to bypass survival signals 
from the pre-B cell receptor that are 
normally required for B cell survival. But 
exactly how BCR–ABL1 ensures B cell 
survival in the absence of pre-B cell 
receptor signals was not completely clear.
Feldhahn et al. now show that 
Bruton’s tyrosine kinase (BTK)—a key 
component of the pre-B cell receptor 
signaling pathway—is perpetually 
The oncogene BCR–ABL1 induces the synthesis of a splice variant of Bruton’s tyrosine kinase 
(BTKp52) that hijacks full-length BTK and transforms B cells.
 
phosphorylated (and thus activated) in 
BCR–ABL1-expressing leukemia cells. 
Downstream signals, including calcium 
flux and expression of the pro-survival 
protein Bcl-xL, were also activated in 
these cells. BTK phosphorylation depended 
on the kinase activity of BCR–ABL1, as 
inhibiting this kinase decreased BTK 
phosphorylation. But the mechanism 
was mysterious, as previous studies had 
ruled out a direct interaction between 
BCR–ABL1 and BTK.
The authors had noted that several 
kinase-deficient splice variants of BTK 
accumulated in leukemia cells. One of 
these variants (BTK
 
p52
 
) bound to both 
BCL–ABL1 and full-length BTK, 
providing a bridge that allowed BCR–
ABL1 to phosphorylate full-length BTK. 
BTK
 
p52
 
 was needed to maintain cell 
survival, as removal of this protein drove 
the cells into apoptosis. Remarkably, the 
BCR–ABL1 protein itself triggered the 
production of the BTK splice variants, a 
finding consistent with previous studies 
showing that BCR–ABL1 induces the 
expression of proteins involved in RNA 
splicing.
 
Imaging tolerance
 
The behavior of naive T cells in the lymph nodes does not
betray their fate, according to new footage from live lymph
nodes. On page 1815, Zinselmeyer and colleagues show
that the movements of CD4
 
 
 
 T cells destined for tolerance
differ only subtly from those destined for priming, suggesting
that tolerance cannot be explained by an overt failure of the
T cells to stop so that they can receive a priming signal.
Intravital imaging technology has revealed that naive T cells
dart rapidly around lymph nodes in search of their antigen,
briefly contacting antigen presenting cells (APCs) as they go. An
encounter with a cognate antigen delivers a stop signal that
triggers stable T cell–APC interactions. When this encounter
breaks up, the T cells resume their frenetic activity.
3-dimensional plots of CD4  T cell movement in lymph nodes 
during priming (left) or tolerizing (right) conditions uncover 
only subtle differences.
 
Interactions between T cells and APCs may, under certain
conditions, lead to T cell tolerance instead of priming. Disrup-
tion of the choreographed T cell behavior in the lymph node
is one possible explanation for the distinct functional out-
comes. This idea was supported by a recent study showing that
CD8
 
 
 
 T cells failed to form stable interactions with dendritic
cells under tolerizing conditions, suggesting that the lack of a
prolonged signal from the APC may lead to T cell tolerance.
Zinselmeyer et al. now show, however, that CD4
 
 
 
 T
cells in lymph nodes of mice fed antigen with or without
adjuvant (to induce priming or tolerance) behaved similarly.
Under both conditions, naive T cells formed stable clusters
with APCs, although the clusters were smaller and shorter-
lived under tolerizing conditions. The authors suggest that
subtle differences in T cell clustering, and perhaps the quality
of the signal delivered by the APC—rather than the complete
presence or absence of a stable interaction—may decide the
fate of the T cell.
Shakhar and colleagues, reporting in 
 
Nature Immunology
 
(doi:10.1038/ni1210), also found only subtle differences in
CD4
 
 
 
 T cell behavior in priming or tolerizing conditions.
They found that stable T–DC interactions were predictive of
T cell activation and proliferation, but not tolerance induction.
They speculate that late, dynamic T cell-APC interactions
that occur after the T cells resume their motion may deliver
the fate-deciding signal.
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Brain-tethered T cells
 
On page 1805, Kawakami et al. show that 
antigen-specific CD4
 
 
 
 T cells that attack the 
brain become stationary within brain tissue, 
whereas nonspecific T cells cruise through 
without stopping. These intravital images—the 
first to capture T cells launching an autoimmune 
attack on the brain—suggest that antigen-
specific T cells behave similarly in dense brain 
tissue as they do in lymph nodes.
Activated CD4
 
 
 
 T cells specific for the 
endogenous brain protein myelin basic protein 
(MBP) trigger fatal encephalomyelitis in a rat 
model of multiple sclerosis. These cells migrate 
into the central nervous system (CNS) where 
they become reactivated.
Previous studies by this group showed that both antigen-specific and 
nonspecific T cells gain access to the CNS, but only specific cells become 
reactivated once there. Kawakami et al. now show that a subset of MBP-specific 
T cells—likely those that have encountered antigen—stopped moving inside 
the brain, appearing tethered to a fixed point. T cells specific for a control 
antigen kept moving, suggesting that the presence of antigen was required 
for T cells to stop moving and to trigger disease.
The authors were surprised to find that T cells move as rapidly through the 
dense brain tissue as in the more aqueous environment of the lymph nodes. How 
they do this is not known but the authors suggest that the T cells may produce 
proteases that help clear a path through the compact tissue.
A subset of MBP-specific 
T cells (green) become 
stationary in the brain 
during EAE, presumably 
after engaging their antigen 
on antigen-presenting cells 
(red).
 
Signaling commitment
 
A histone modification thought by many to be a crude bulldozer can
contribute to the fine molding of cell behavior, according to a study
on page 1825. Rossig et al. show that histone deacetylase (HDAC)
activity is required for adult progenitor cells to commit to the endothelial
cell lineage. In these cells, HDAC activity was specifically required for the
induction of the transcription factor HoxA9, which may be a master
regulator of endothelial cell commitment.
HoxA9 was able to drive cell differentiation due to its ability to
activate the expression of endothelial cell–specific genes, including
endothelial cell nitric oxide synthase (eNOS). In addition, HoxA9-
deficient mice were unable to recover from ischemic injury, a pro-
cess that requires formation of new endothelial cells from circulating
progenitors.
But the involvement of HDACs in this process may seem counter-
intuitive, as histone deacetylation of gene promoter elements is normally
associated with transcriptional silencing. Indeed, recent reports showed
that eNOS expression itself is suppressed by HDAC activity in nonen-
dothelial cells.
The protein complex responsible for activating HoxA9 expression
was, however, recently shown to contain HDAC proteins. HDACs can
modify nonhistone proteins, including transcription factors, and the
acetylation or deacetylation state of these factors can influence target gene
activation. The authors suspect that modification of nonhistone proteins
may govern the induction of HoxA9.
 
The mark of T reg cells
 
Regulatory T (T reg) cells found in the synovial
fluid of inflamed joints can be identified by
the coexpression of CD4, CD25, and CD27,
according to Ruprecht and colleagues on
page 1793.
Suppression of damaging T cell responses by
CD4
 
 
 
 T reg cells is critical for the prevention of
autoimmune disease. But studying these cells
in the context of disease has been problematic,
largely because CD4
 
 
 
 T reg cells and activated
CD4
 
 
 
 T cells express many of the same surface
molecules and are thus difficult to distinguish.
Although coexpression of CD4 and the high
affinity interleukin (IL)-2 receptor (CD25)
identifies T reg cells in the circulation,
CD25 cannot distinguish between T reg cells
and local effector T cells, which up-regulate
this molecule upon activation.
Ruprecht et al. now show that CD4
 
 
 
CD25
 
 
 
 T reg cells found in the inflamed joints
of children with autoimmune arthritis can be
distinguished from their CD4
 
 
 
CD25
 
 
 
 effector
T cell counterparts by the expression of the
TNF receptor family member CD27—a mole-
cule that is down-regulated on activated T
cells. CD27 expression identified T reg cells in
these patients, as the ability to suppress T cell
proliferation in vitro resided solely in the
CD4
 
 
 
CD25
 
 
 
CD27
 
 
 
 T cell subset.
But why does an autoimmune response
develop in these patients despite an abun-
dance of T reg cells at the site of disease? The
authors suggest that the cytokines IL-7 and
IL-15, which were detected in the patients’
synovial fluid, might be to blame, as the
combination of these cytokines reversed the
in vitro ability of the T reg cells to inhibit T
cell proliferation.
CD4  regulatory T cells in the synovial tissues of a 
juvenile arthritis patient coexpress CD25 (red) 
and CD27 (green). 
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